Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

In an experimentally-induced DTH model of MS, we examined mRNA and protein expression of a range of MMPs and of TNFalpha to establish the contribution that individual MMPs might make to the pathogenesis. In control rat brain, mRNA for all of the MMPs examined was detectable. However, by immunohistoc...

Bibliografske podrobnosti
Main Authors:	Anthony, D, Miller, K, Fearn, S, Townsend, M, Opdenakker, G, Wells, G, Clements, J, Chandler, S, Gearing, A, Perry, V
Format:	Journal article
Jezik:	English
Izdano:	1998

Podobne knjige/članki

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
od: Chandler, S, et al.
Izdano: (1997)

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
od: Anthony, D, et al.
Izdano: (1997)

CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features.
od: Green, J, et al.
Izdano: (2011)

Reduction of excitotoxicity and associated leukocyte recruitment by a broad-spectrum matrix metalloproteinase inhibitor.
od: Campbell, S, et al.
Izdano: (2004)

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
od: Anthony, D, et al.
Izdano: (2009)

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.
od: Newman, T, et al.
Izdano: (2001)

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
od: Jurynczyk, M, et al.
Izdano: (2017)

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis
od: Kaufmann, M, et al.
Izdano: (2021)

Progress in matrix metalloproteinase research.
od: Murphy, G, et al.
Izdano: (2008)

Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
od: Anthony, D, et al.
Izdano: (2014)

Matrix metalloproteinases in cancer.
od: Itoh, Y, et al.
Izdano: (2002)

COOPERATION BETWEEN IL-4 AND IL-10 RESULTS IN INHIBITION OF DTH RESPONSES
od: Powrie, F, et al.
Izdano: (1993)

Structure and function of matrix metalloproteinases and TIMPs.
od: Nagase, H, et al.
Izdano: (2006)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
od: Visse, R, et al.
Izdano: (2003)

Axon damage and repair in multiple sclerosis.
od: Perry, V, et al.
Izdano: (1999)

Unique aspects of acute inflammation in the CNS
od: Perry, V, et al.
Izdano: (1997)

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
od: Miyamori, H, et al.
Izdano: (2001)

Microglia activation and inflammation in the CNS
od: Perry, V, et al.
Izdano: (1996)

Localizing matrix metalloproteinase activities in the pericellular environment.
od: Murphy, G, et al.
Izdano: (2011)

In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis.
od: Lim, N, et al.
Izdano: (2014)

CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.
od: Evans, M, et al.
Izdano: (2014)

Matrix metalloproteinases are elevated in the urine of patients with endometriosis.
od: Becker, C, et al.
Izdano: (2010)

Matrix metalloproteinases and their inhibitors in human vitreous.
od: De La Paz, MA, et al.
Izdano: (1998)

A personal journey with matrix metalloproteinases
od: Nagase, H
Izdano: (2016)

Role of cell surface matrix metalloproteinases
od: Itoh, Y, et al.
Izdano: (2001)

Ras, metastasis, and matrix metalloproteinase 9.
od: Bernhard, E, et al.
Izdano: (2001)

The evidence for primary axonal loss in multiple sclerosis
od: Anthony, D, et al.
Izdano: (2000)

[The evidence for primary axonal loss in multiple sclerosis]
od: Anthony, D, et al.
Izdano: (2000)

Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo.
od: Nonaka, T, et al.
Izdano: (2005)

Selective hydrolysis of triple-helical peptides by matrix metalloproteinases
od: Lauer-Fields, J, et al.
Izdano: (2000)

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.
od: Lee, M, et al.
Izdano: (1999)

Matrix metalloproteinases in acute coronary syndromes: current perspectives.
od: Kampoli, A, et al.
Izdano: (2012)

Degradation of interleukin 1beta by matrix metalloproteinases.
od: Ito, A, et al.
Izdano: (1996)

Importance of matrix metalloproteinases in human trophoblast invasion.
od: Bischof, P, et al.
Izdano: (1995)

The role of matrix metalloproteinases in rheumatoid tendon disease.
od: Jain, A, et al.
Izdano: (2002)

Matrix metalloproteinase biology applied to vitreoretinal disorders.
od: Sethi, C, et al.
Izdano: (2000)

Membrane-type matrix metalloproteinases: Their functions and regulations
od: Itoh, Y
Izdano: (2015)

White matter damage is associated with matrix metalloproteinases in vascular dementia.
od: Rosenberg, G, et al.
Izdano: (2001)

White matter damage is associated with matrix metalloproteinases in Binswanger's disease
od: Rosenberg, G, et al.
Izdano: (2001)

The systemic response to CNS injury.
od: Anthony, D, et al.
Izdano: (2014)